Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy.

Cochrane Database Syst Rev · 2025 · PMC12461785 · PMID 40995828

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

showed a trendP = 0.097so close (0.05 < p ≤ 0.1)

In the JCOG 9104 trial, which compared concurrent versus sequential radiotherapy, the concurrent group showed a trend toward longer overall survival (median 27.2 versus 19.7 months, P = 0.097) and acceptable toxicity [ 21 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.